Exploratory Study of NS-089/NCNP-02 in Duchenne Muscular Dystrophy
Latest Information Update: 22 Jan 2025
At a glance
- Drugs Brogidirsen (Primary)
- Indications Duchenne muscular dystrophy
- Focus Adverse reactions
Most Recent Events
- 10 Jan 2025 Results published in the Nippon Shinyaku Co., Ltd Media Release
- 28 Sep 2022 Status changed from active, no longer recruiting to completed.
- 08 Apr 2022 Planned End Date changed from 31 Dec 2021 to 31 May 2022.